send to a friend by email

Birzeit Pharmaceuticals earns a net income of USD 2.98 million in H1 2013

2013-08-12

According to company data for the first six months of the year, net profit after taxes reached 2,979,329 USD, compared with a net profit after taxes of 2,293,221 USD from the first six months of 2012, a net increase of 29.9%. Total assets of the company reached 60,583,869 USD as of June 30^th, 2013, compared to total assets of 59,958,678 USD as of December 31^st, 2012, a net increase of 1.0%. Total liabilities of the company reached 11,351,467 USD as of June 30^th, 2013, compared to total liabilities of 11,736,829 USD as of December 31^st, 2012, a net decrease of 3.3%. Net ownership equity of the company reached 49,232,402 USD (including 305,642 USD in Non-controlling interest) as of June 30^th, 2013, compared with a net ownership equity of 48,221,849 USD (including 336,020 USD in Non-controlling interest) as of December 31^st, 2012, a net increase of 2.1% in the last six months. Furthermore, paid-in capital increased from 18,490,177 USD on December 31^st, 2012 to 18,502,825 USD by June 30^th, 2013, an increase of 0.1%.